Alan T. Remaley
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 154
- Cholesterol and Lipid Metabolism 92
- Lipoproteins and Cardiovascular Health 70
-
- Peroxisome Proliferator-Activated Receptors 34
- Co-authors
- Kasey C. Vickers (13 shared papers)Robert D. Shamburek (30 shared papers)Bassem M. Shoucri (4 shared papers)Brian T. Palmisano (3 shared papers)Marcelo Amar (53 shared papers)H. Bryan Brewer (17 shared papers)Silvia Santamarina-Fojo (20 shared papers)John A. Stonik (25 shared papers)
- Journals
- Journal of Lipid Research (23 papers)Clinical Chemistry (23 papers)Journal of Biological Chemistry (20 papers)Arteriosclerosis Thrombosis and Vascular Biology (19 papers)Journal of clinical lipidology (11 papers)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Alan T. Remaley
380 papers receiving 22.3k citations
Alan T. Remaley's Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 4.5k
- Endocrinology, Diabetes and Metabolism 4.1k
- Surgery 7.5k
- Molecular Biology 7.9k
- Biochemistry 787
Countries citing papers authored by Alan T. Remaley
This map shows the geographic impact of Alan T. Remaley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan T. Remaley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan T. Remaley more than expected).
Fields of papers citing papers by Alan T. Remaley
This network shows the impact of papers produced by Alan T. Remaley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan T. Remaley. The network helps show where Alan T. Remaley may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan T. Remaley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 386 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Hit paper breakdown → | 2011 | 2237 |
| 2 | PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Hit paper breakdown → | 2001 | 991 |
| 3 | Cholesterol Efflux and Atheroprotection Hit paper breakdown → | 2012 | 748 |
| 4 | HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events Hit paper breakdown → | 2011 | 396 |
| 5 | 2008 | 396 | |
| 6 | 2014 | 343 | |
| 7 | NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis Hit paper breakdown → | 2018 | 341 |
| 8 | A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia Hit paper breakdown → | 2020 | 331 |
| 9 | 2007 | 283 | |
| 10 | 2001 | 274 | |
| 11 | 2001 | 269 | |
| 12 | 2012 | 268 | |
| 13 | 2010 | 262 | |
| 14 | 2001 | 231 | |
| 15 | 2014 | 225 | |
| 16 | 1999 | 218 | |
| 17 | 2013 | 217 | |
| 18 | HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research Hit paper breakdown → | 2021 | 216 |
| 19 | High-density lipoprotein revisited: biological functions and clinical relevance Hit paper breakdown → | 2022 | 213 |
| 20 | 2011 | 195 |
About Alan T. Remaley
Alan T. Remaley is a scholar working on Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 386 papers that have together received 22.7k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (92 papers), Lipoproteins and Cardiovascular Health (70 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (68 papers), Drug Transport and Resistance Mechanisms (46 papers), Cancer, Lipids, and Metabolism (40 papers), Peroxisome Proliferator-Activated Receptors (34 papers), Adipokines, Inflammation, and Metabolic Diseases (14 papers) and Atherosclerosis and Cardiovascular Diseases (14 papers). The work is most often cited by research in Cancer Research (4.5k citations), Endocrinology, Diabetes and Metabolism (4.1k citations), Surgery (7.5k citations), Molecular Biology (7.9k citations) and Biochemistry (787 citations). Alan T. Remaley has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Kasey C. Vickers, Robert D. Shamburek, Bassem M. Shoucri, Brian T. Palmisano, Marcelo Amar, H. Bryan Brewer, Silvia Santamarina-Fojo, John A. Stonik, Maureen Sampson and Edward B. Neufeld. Their work appears in journals such as Journal of Lipid Research, Clinical Chemistry, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Journal of clinical lipidology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.